Heterogeneous Fenton Reaction Enabled Selective Colon Cancerous Cell Treatment

A selective colon cancer cell therapy was effectively achieved with catalase-mediated intra-cellular heterogeneous Fenton reactions triggered by cellular uptake of SnFe(2)O(4) nanocrystals. The treatment was proven effective for eradicating colon cancer cells, whereas was benign to normal colon cells, thus effectively realizing the selective colon cancer cell therapeutics. Cancer cells possess much higher innate hydrogen peroxide (H(2)O(2)) but much lower catalase levels than normal cells. Catalase, an effective H(2)O(2) scavenger, prevented attacks on cells by reactive oxygen species induced from H(2)O(2). The above intrinsic difference between cancer and normal cells was utilized to achieve selective colon cancer cell eradication through endocytosing efficient heterogeneous Fenton catalysts to trigger the formation of highly reactive oxygen species from H(2)O(2). In this paper, SnFe(2)O(4) nanocrystals, a newly noted outstanding paramagnetic heterogeneous Fenton catalyst, have been verified an effective selective colon cancerous cell treatment reagent of satisfactory blood compatibility.